Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Palacios, Ana
GRAFD, NCT04502823: Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler	Completed	N/A	1088	Europe	Management based on sFlt-1/PlGF values	Hospital Universitari Vall d'Hebron Research Institute	Fetal Growth Retardation	12/22	12/22
WAvES, NCT05648344: WW Improving Nutrition Study: A Randomized Controlled Trial	Active, not recruiting	N/A	376	US	WW, Control	Georgia Southern University, Weight Watchers International, Indiana University	Overweight and Obesity	11/23	11/24
NCT04721197: Hens Hatching Hope	Recruiting	N/A	400	RoW	Egg vouchers, Standard of Care	Georgia Southern University, Shoulder to Shoulder	Malnutrition, Child	01/26	01/26
early GRAFD, NCT05284474: Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler	Not yet recruiting	N/A	340	Europe	soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)	Hospital Universitari Vall d'Hebron Research Institute, Instituto de Salud Carlos III, Roche Diagnostics GmbH	Fetal Growth Retardation, Preeclampsia, Placenta Diseases	09/26	12/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Palacios, Ana
GRAFD, NCT04502823: Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler	Completed	N/A	1088	Europe	Management based on sFlt-1/PlGF values	Hospital Universitari Vall d'Hebron Research Institute	Fetal Growth Retardation	12/22	12/22
WAvES, NCT05648344: WW Improving Nutrition Study: A Randomized Controlled Trial	Active, not recruiting	N/A	376	US	WW, Control	Georgia Southern University, Weight Watchers International, Indiana University	Overweight and Obesity	11/23	11/24
NCT04721197: Hens Hatching Hope	Recruiting	N/A	400	RoW	Egg vouchers, Standard of Care	Georgia Southern University, Shoulder to Shoulder	Malnutrition, Child	01/26	01/26
early GRAFD, NCT05284474: Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler	Not yet recruiting	N/A	340	Europe	soluble fms-like tyrosine kinase to placental growth factor ratio (sFlt-1/PlGF)	Hospital Universitari Vall d'Hebron Research Institute, Instituto de Salud Carlos III, Roche Diagnostics GmbH	Fetal Growth Retardation, Preeclampsia, Placenta Diseases	09/26	12/26